A potential biomarker hsa-miR-200a-5p distinguishing between benign thyroid tumors with papillary hyperplasia and papillary thyroid carcinoma

• Xian Wang,

  Roles Writing – original draft

  Affiliations Department of Pathology, Anhui Medical University, Hefei, Anhui, China, Department of Pathology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China

  ⨯
• Shan Huang,

  Roles Data curation

  Affiliations Department of Pathology, Anhui Medical University, Hefei, Anhui, China, Department of Pathology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China

  ⨯
• Xiaocan Li,

  Roles Conceptualization

  Affiliation Department of Pathology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China

  ⨯
• Dongrui Jiang,

  Roles Methodology

  Affiliation Department of Pathology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China

  ⨯
• Hongzhen Yu,

  Roles Methodology

  Affiliations Department of Pathology, Anhui Medical University, Hefei, Anhui, China, Department of Pathology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China

  ⨯
• Qiang Wu,

  Roles Data curation

  Affiliation Department of Pathology, Anhui Medical University, Hefei, Anhui, China

  ⨯
• Chaobing Gao ,

  Roles Writing – review & editing

  * E-mail: gcbl10011@163.com (CG); woozson@126.com (ZW)

  Affiliation Department of Otorhinolaryngology, Head and Neck Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China

  ⨯
• Zhengsheng Wu

  Roles Conceptualization, Writing – review & editing

  * E-mail: gcbl10011@163.com (CG); woozson@126.com (ZW)

  Affiliation Department of Pathology, Anhui Medical University, Hefei, Anhui, China

  http://orcid.org/0000-0002-7571-8215

  ⨯